Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study
- 30 April 2011
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 158 (4), 644-649.e1
- https://doi.org/10.1016/j.jpeds.2010.10.012
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Summary of worldwide pediatric malignancies reported after exposure to etanerceptPediatric Rheumatology, 2010
- Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki DiseaseThe Journal of Pediatrics, 2008
- Resistance to Intravenous Immunoglobulin in Children with Kawasaki DiseaseThe Journal of Pediatrics, 2008
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJama-Journal Of The American Medical Association, 2006
- Serious liver disease induced by infliximabClinical Rheumatology, 2006
- Infliximab treatment for refractory Kawasaki syndromeThe Journal of Pediatrics, 2005
- Plasma exchange for refractory Kawasaki diseaseEuropean Journal of Pediatrics, 2004
- Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesionsClinical Immunology and Immunopathology, 1990
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinThe New England Journal of Medicine, 1986
- Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adultsThe Journal of Pediatrics, 1978